Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...

That this is the first time a compulsory licence has been granted in India is in itself important. INDIA'S long struggle to ensure access to affordable medicines for its people recently took a positive and interesting turn. In early March, just before he demitted office, Controller General of Patents P.H. Kurian passed an order on an application filed by Natco Pharma, headquartered in Hyderabad, requesting a licence to produce an anti-cancer...

Nearly 138 million Indian smokers do not know that smoking tobacco causes stroke. As many as 92 million on the other hand aren't aware that tobacco causes heart disease. According to a report released on Friday by the World Heart Federation, half of all Chinese smokers and one-third of Indian and Vietnamese smokers are unaware of the risks tobacco poses to our heart. Awareness of the risk of second-hand smoke is even lower. Around...

The ICDS' plight is symptomatic of the problems plaguing the Union government's flagship schemes for the poor all over the country.   INDIA may be the only country in the world where we describe the ensuring of the basic socio-economic rights of the people in terms of “flagship schemes” that are seen as the benevolent contribution of governments. One problem with this approach is that the delivery of basic services is...

Each time 25 year old Salma takes her one year old son Zubair to the Batla Clinic (a private clinic in Delhi) for a shot of the DPT, the cost of transportation and the vaccine adds up to approximately Rs.500.   When it is time for Zubair to take the next immunization dose, Salma may find that the expenses have entirely spiraled out of her reach. New vaccines and expensive brands of baby...